8.6.2021 16:05:44 CEST | Demant A/S |
Ledende medarbejderes transaktioner
Selskabsmeddelelse nr. 2021-10
8. juni 2021
Ledende medarbejderes og disses nærtståendes transaktioner med Demant-aktier
Indberetning i henhold til markedsmisbrugsforordningens artikel 19, stk. 1, litra a, af ledende medarbejderes og disses nærtståendes transaktioner med Demant-aktier:
1.
Nærmere oplysninger om personen med ledelsesansvar/personen med nær tilknytning til denne
a)
Navn
Niels Jacobsen
2.
Årsag til indberetningen
a)
Stilling/titel
Næstformand for bestyrelsen
b)
Første indberetning/ændring
Første indberetning
3.
Nærmere oplysninger om udstederen, deltageren på markedet for emissionskvoter, auk-tionsplatformen, auktionsholderen eller den auktionstilsynsførende
a)
Navn
Demant A/S
b)
LEI-kode
213800RM6L9LN78BVA56
4.
Nærmere oplysninger om transaktionen/transaktionerne: Gentages for i) hver type instrument, ii) hver type transaktion, iii) hver dato og iv) hvert sted, hvor der er udført transaktioner
a)
Beskrivelse af det finansielle
instrument, instrumenttypen
Identifikationskode
Aktier
DK0060738599
b)
Transaktionens art
Salg
c)
Pris(er) og mængde(r)
Pris Mængde
DKK 350,21 100.000 stk.
Min. pris DKK 348,25
Max. pris DKK 354,30
d)
Aggregerede oplysninger:
– Aggregeret mængde
– Pris
100.000 stk.
DKK 350,21
e)
Dato for transaktionen
7. juni 2021
f)
Sted for transaktionen
Nasdaq Copenhagen A/S
Yderligere information:
Mathias Holten Møller, Head of Investor Relations
Christian Lange, Investor Relations Officer
Trine Kromann-Mikkelsen, VP Corporate Communications and Relations
Telefon +45 3917 7300
www.demant.com
Om Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Vedhæftninger
2021-10 Indberetning om aktiesalg.pdf
8.6.2021 16:05:44 CEST | Demant A/S |
Managers' Transactions
Company announcement no 2021-10
8 Juni 2021
Transactions with Demant shares by senior executives and closely related parties
Notification on transactions with Demant shares by senior executives and closely related parties pursuant to article 19, sub-article 2a, of the Market Abuse Regulation:
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Niels Jacobsen
2.
Reason for the notification
a)
Position/status
Deputy Chairman of the Board of Directors
b)
Initial notification/amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
a)
Name
Demant A/S
b)
LEI
213800RM6L9LN78BVA56
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial
instrument, type of instrument
Identication code
Shares
DK0060738599
b)
Nature of the transaction
Sale
c)
Price(s) and volume(s)
Price Volume
DKK 350.21 100,000 shares
Minimum price DKK 348.25
Maximum price DKK 354.30
d)
Aggregated information:
– Aggregated volume
– Price
100,000 shares
DKK 350.21
e)
Date of the transaction
7 June 2021
f)
Place of the transaction
Nasdaq Copenhagen A/S
Further information:
Mathias Holten Møller, Head of Investor Relations
Christian Lange, Investor Relations Officer
Trine Kromann-Mikkelsen, VP Corporate Communications and Relations
Phone +45 3917 7300
www.demant.com
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Attachments
2021-10 Notifcation of sale of shares.pdf
